Ads
related to: is belimumab approved for lupus patients to work- BENLYSTA Cares
Talk To Trained Nurses Live To Ask
Questions About The Medication Now.
- Dosing & Admin Info
Learn About Dosing & Administration
And Find Helpful Resources & Info.
- Risks And Side Effects
Read The Potential Risks & Common
Side Effects That May Occur.
- BENLYSTA Cares Line
Call Trained Nurses Who Can Answer
Questions About Taking Benlysta.
- About BENLYSTA
Discover More About BENLYSTA
At The Official Site Today.
- BENLYSTA Information
Find Injection Training Resources
On The Official Patient Website.
- BENLYSTA Cares
Search results
Results From The WOW.Com Content Network
Belimumab, sold under the brand name Benlysta, is a human monoclonal antibody that inhibits B-cell activating factor (BAFF), [6] also known as B-lymphocyte stimulator (BLyS). [7] It is approved in the United States [8] and Canada, [9] and the European Union [5] to treat systemic lupus erythematosus and lupus nephritis. [10]
AstraZeneca's Saphnelo, approved in 2021, made $280 million in 2023 sales, while GSK's Benlysta, which first gained approval in 2011, brought in 1.35 billion euros ($1.50 billion) last year.
In the new NHS trial, three patients have received the therapy for the most serious form of lupus, a condition that can be life-threatening and cause damage to the heart, lungs, brain and kidneys.
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Belimumab is a monoclonal antibody that inhibits B-cell activating factor and thereby inflammation. It was approved in 2019 by the US Food and Drug Administration to treat the musculoskeletal, cutaneous, and cardiac manifestations of children with cSLE who are over 5 years old. It is given intravenously to cSLE patients with active disease but ...
Halsey announced in a June 5 Instagram post that she has lupus, an autoimmune disease which was diagnosed in 2022, and a rare white blood-cell disorder. In a prior post announcing the release of ...
Ads
related to: is belimumab approved for lupus patients to work